About Aldehyde dehydrogenase family 3 member B2
Aldehyde dehydrogenase family 3 member B2 (ALDH3B2) is a protein
from Homo sapiens identified by UniProt accession
P48448, 385 residues long.
MolForge cross-references it against 0 known binders and
45 disease associations.
Target properties
| Protein name | Aldehyde dehydrogenase family 3 member B2 |
| UniProt accession | P48448 |
| Gene | ALDH3B2 |
| Organism | Homo sapiens |
| Length | 385 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (45)
Diseases linked to this target (Open Targets).
- BMI-adjusted hip circumference · score 0.16
- cholangiocarcinoma · score 0.08
- esophageal squamous cell carcinoma · score 0.07
- esophageal adenocarcinoma · score 0.04
- BMI-adjusted waist circumference · score 0.04
- non-small cell lung carcinoma · score 0.03
- Barrett's esophagus · score 0.03
- serum metabolite measurement · score 0.03
- hair colour measurement · score 0.02
- mean platelet volume · score 0.02
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P48448-F1 | alphafold | PREDICTED | 95.14 | — |
Amino-acid sequence (385 residues)
MKDEPRSTNL FMKLDSVFIW KEPFGLVLII APWNYPLNLT LVLLVGALAA GSCVVLKPSE ISQGTEKVLA EVLPQYLDQS CFAVVLGGPQ ETGQLLEHKL DYIFFTGSPR VGKIVMTAAT KHLTPVTLEL GGKNPCYVDD NCDPQTVANR VAWFCYFNAG QTCVAPDYVL CSPEMQERLL PALQSTITRF YGDDPQSSPN LGHIINQKQF QRLRALLGCS RVAIGGQSNE SDRYIAPTVL VDVQETEPVM QEEIFGPILP IVNVQSVDEA IKFINRQEKP LALYAFSNSS QVVNQMLERT SSGSFGGNEG FTYISLLSVP FGGVGHSGMG RYHGKFTFDT FSHHRTCLLA PSGLEKLKEI HYPPYTDWNQ QLLRWGMGSQ SCTLL
Explore Aldehyde dehydrogenase family 3 member B2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets